Identification of genes required for resistance to peptidomimetic antibiotics by transposon sequencing by Vitale, Alessandra et al.








Identification of genes required for resistance to peptidomimetic antibiotics
by transposon sequencing
Vitale, Alessandra ; Pessi, Gabriella ; Urfer, Matthias ; Locher, Hans H ; Zerbe, Katja ; Obrecht, Daniel
; Robinson, John A ; Eberl, Leo
Abstract: Pseudomonas aeruginosa is an opportunistic human pathogen and a leading cause of nosocomial
infections. Due to its high intrinsic and adaptive resistance to antibiotics, infections caused by this
organism are difficult to treat and new therapeutic options are urgently needed. Novel peptidomimetic
antibiotics that target outer membrane (OM) proteins have shown great promise for the treatment of P.
aeruginosa infections. Here, we have performed genome-wide mutant fitness profiling using transposon
sequencing (Tn-Seq) to identify resistance determinants against the recently described peptidomimetics
L27-11, compounds 3 and 4, as well as polymyxin B2 (PMB) and colistin (COL). We identified a set of
13 core genes that affected resistance to all tested antibiotics, many of which encode enzymes involved
in the modification of the lipopolysaccharide (LPS) or control their expression. We also identified fitness
determinants that are specific for antibiotics with similar structures that may indicate differences in their
modes of action. These results provide new insights into resistance mechanisms against these peptide
antibiotics, which will be important for future clinical development and efforts to further improve their
potency.
DOI: https://doi.org/10.3389/fmicb.2020.01681






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Vitale, Alessandra; Pessi, Gabriella; Urfer, Matthias; Locher, Hans H; Zerbe, Katja; Obrecht, Daniel;
Robinson, John A; Eberl, Leo (2020). Identification of genes required for resistance to peptidomimetic
antibiotics by transposon sequencing. Frontiers in Microbiology, 11:1681.
DOI: https://doi.org/10.3389/fmicb.2020.01681
ORIGINAL RESEARCH




Roma Tre University, Italy
Reviewed by:
Francesco Imperi,
Roma Tre University, Italy
Alessandra Polissi,
University of Milan, Italy
Robert E. W. Hancock,







This article was submitted to
Antimicrobials, Resistance
and Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 22 April 2020
Accepted: 26 June 2020
Published: 23 July 2020
Citation:
Vitale A, Pessi G, Urfer M,
Locher HH, Zerbe K, Obrecht D,
Robinson JA and Eberl L (2020)
Identification of Genes Required









Alessandra Vitale1, Gabriella Pessi1, Matthias Urfer2, Hans H. Locher2, Katja Zerbe3,
Daniel Obrecht2, John A. Robinson3 and Leo Eberl1*
1 Department of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland, 2 Polyphor AG, Allschwil, Switzerland,
3 Department of Chemistry, University of Zurich, Zurich, Switzerland
Pseudomonas aeruginosa is an opportunistic human pathogen and a leading cause of
nosocomial infections. Due to its high intrinsic and adaptive resistance to antibiotics,
infections caused by this organism are difficult to treat and new therapeutic options
are urgently needed. Novel peptidomimetic antibiotics that target outer membrane
(OM) proteins have shown great promise for the treatment of P. aeruginosa infections.
Here, we have performed genome-wide mutant fitness profiling using transposon
sequencing (Tn-Seq) to identify resistance determinants against the recently described
peptidomimetics L27-11, compounds 3 and 4, as well as polymyxin B2 (PMB) and
colistin (COL). We identified a set of 13 core genes that affected resistance to all
tested antibiotics, many of which encode enzymes involved in the modification of
the lipopolysaccharide (LPS) or control their expression. We also identified fitness
determinants that are specific for antibiotics with similar structures that may indicate
differences in their modes of action. These results provide new insights into resistance
mechanisms against these peptide antibiotics, which will be important for future clinical
development and efforts to further improve their potency.
Keywords: transposon sequencing, antibiotic resistance, polymyxins, peptidomimetics, Pseudomonas
aeruginosa
INTRODUCTION
Antimicrobial resistance is a global threat for the effective treatment of infections and is a
major cause of mortality (Prestinaci et al., 2015). The rapid spread of antimicrobial resistance
in bacteria is largely driven by antimicrobial exposure, often in connection with the misuse of
antimicrobial compounds in health care and animal husbandry (Baquero et al., 1998; Chantziaras
et al., 2014; Holmes et al., 2016). To restrict the spread of antimicrobial resistance and increased
mortality rate, the World Health Organization developed a framework of regulations early in
the 21st century (WHO, 2001). Yet the emergence of multidrug resistant pathogenic bacteria,
including the so-called ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) is
particularly alarming (Rice, 2008). Among the ESKAPE pathogens, the Gram-negative bacterium
P. aeruginosa is one of the leading sources of nosocomial infections associated with morbidity and
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mortality (Kang et al., 2003). P. aeruginosa is a facultative
anaerobic Gram-negative bacterium, which is able to perform
denitrification in the presence of nitrate or nitrite (Filiatrault
et al., 2005; Williams et al., 2006; Palmer et al., 2007) and
pyruvate/arginine fermentation when nitrate is absent (Eschbach
et al., 2004; Schreiber et al., 2006). Due to its enormous
metabolic versatility, this bacterium can adapt to a wide range of
environments (Frimmersdorf et al., 2010).
The extensive use and misuse of antibiotics belonging to
the polymyxin (POL) family [polymyxin B2 (PMB) and colistin
(COL)], which constitutes the last therapeutic option for the
treatment of some Gram-negative multidrug resistant infections,
has led to the development of resistance to these antibiotics
in different microorganisms (Rice, 2008; Carattoli et al., 2017;
Xiong et al., 2017; Zhang et al., 2017). POLs are cationic peptides
with a high affinity for negatively charged molecules such as the
lipopolysaccharides (LPS) of the outermembrane (OM) of Gram-
negative bacteria (Rabanal and Cajal, 2017). After binding to the
LPS, the POLs displace the bridging divalent cations and initiate
a process leading to permeabilization of the OM (Rabanal and
Cajal, 2017). The lethal action of POLs is thought to be the result
of the depolarizing effect on the cytoplasmic membrane (CM),
but alternative mechanisms such as oxidative stress or interaction
with OM proteins have also been suggested (Storm et al., 1977;
van der Meijden and Robinson, 2015; Yu et al., 2015).
Polymyxin resistance is often associated with modifications to
the LPS. In P. aeruginosa the two-component systems PmrAB,
PhoPQ, ColRS, ParRS, and CprRS control expression of the LPS
modification operon arnBCADTEF, responsible for the addition
of 4-amino-4-deoxy-L-arabinose (L-Ara4N) to lipid A (McPhee
et al., 2003; Olaitan et al., 2014). In addition to LPS modification,
the multidrug efflux system MexXY–OprM was demonstrated
to increase the fitness of the organism in the presence of POLs
(Baron et al., 2016; Puja et al., 2020). Previous work has shown
that a low concentration of magnesium (Mg2+), which is sensed
via the PhoPQ and PmrAB systems (McPhee et al., 2006), induces
expression of the arn operon and consequently leads to POL
resistance (Brown and Melling, 1969; Brown and Watkins, 1970;
Groisman et al., 1997). Mg2+ limitation not only triggers LPS
modification but also induces quorum sensing, biofilm formation
and the production of the virulence factors phenazine and
pyochelin (Guina et al., 2003; Mulcahy and Lewenza, 2011).
Novel cationic peptidomimetic antibiotics have recently been
reported (Robinson, 2013) that show potent and selective action
against Pseudomonas spp., including the opportunistic pathogen
P. aeruginosa (Srinivas et al., 2010; Werneburg et al., 2012;
Schmidt et al., 2013; Urfer et al., 2016). These antimicrobial
compounds include L27-11 and the closely related clinical
candidate murepavadin (also known as POL7080; Wach et al.,
2018), which has a very low minimum inhibitory concentration
(MIC90 2 µg/mL) against P. aeruginosa (Ekkelenkamp et al.,
2020). These compounds target the OM protein LptD, which
is required for the transport of LPS to the OM (Srinivas
et al., 2010; Werneburg et al., 2012; Schmidt et al., 2013).
A more recently described family of chimeric peptides (referred
to as chimeras), including compounds 3 and 4, show potent
bactericidal activity against all the Gram-negative ESKAPE
pathogens E. coli, P. aeruginosa,A. baumanii, andK. pneumoniae.
These compounds bind to both LPS and the main component
(BamA) of the β-barrel folding complex (BAM; Figures 1A,B)
required for the folding and insertion of β-barrel proteins
into the OM of Gram-negative bacteria (Luther et al., 2019).
At present, these antimicrobial peptides are in preclinical
development, however, knowledge about the mechanisms
of resistance against these new classes of peptidomimetic
antibiotics is scarce.
Several methods have been employed to identify intrinsic
and adaptive resistance factors, including the isolation and
characterization of resistant mutants (Fernández et al., 2013;
Gutu et al., 2013) and the genome-wide analysis of gene
expression of bacteria grown in the presence of sub-minimal
inhibitory concentrations (sub-MICs) of the antibiotics (Cheah
et al., 2016; Khaledi et al., 2016). The recently developed high-
throughput transposon sequencing (Tn-Seq) technique has been
demonstrated to be an alternative method to gain mechanistic
insights into multidrug resistance mechanisms (Gallagher et al.,
2011; Murray et al., 2015). Tn-Seq involves creating a saturated
transposon (Tn) library of mutants, next-generation sequencing
of the Tn insertion, and mapping the insertion sites to a
reference genome. This technique has been widely used to
identify genes that provide a fitness benefit for growth under
a particular condition, as mutants with a growth defect would
be depleted compared to a respective control culture (Murray
et al., 2015; Solaimanpour et al., 2015; Rajagopal et al., 2016;
Santiago et al., 2018).
In this study, we constructed a highly saturated Tn insertion
library in the model organism P. aeruginosa University of
California Berkeley Plant Pathology (UCBPP)-PA14 and used
Tn-Seq to identify genes that provide a fitness benefit for
growth in the presence of sub-MICs of PMB, COL and the
novel peptidomimetic antibiotics L27-11, 3, and 4 (Figure 1C).
Our data show that LPS modification influences susceptibility
to all the antibiotics tested. However, we also identified
distinct resistance determinants for each of the antibiotics,
indicating differences in the mechanisms of resistance. Finally,
we demonstrate that the production of spermidine promotes
resistance against POLs and L27-11.
RESULTS
Construction and Growth of a
P. aeruginosa UCBPP-PA14 Transposon
Library in the Presence of Sub-Lethal
Concentrations of Different Peptide
Antibiotics
A modified version of the suicide plasmid pLG99 (pLG99-Gm),
which carries Tn23 (Gallagher et al., 2013), was used to generate
more than 500,000 insertion mutants in P. aeruginosa UCBPP-
PA14. The Tn5 derivative Tn23 inserts randomly in the genome
(Gallagher et al., 2013). In order to challenge the Tnmutants with
the antibiotics, we first determined the MICs of PMB, COL and
the peptidomimetic antibiotics L27-11, 4 and 3 in P. aeruginosa
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FIGURE 1 | Experimental set-up of the transposon sequencing (Tn-Seq) analysis. (A) Structures of the five antibiotics employed in this study (B) and their cellular
targets. Polymyxins (POLs) permeabilize the OM, leading to cytoplasmic membrane (CM) depolarization and cell lysis. Chimeras 3 and 4 bind to both
lipopolysaccharide (LPS) and BamA, the main component of the β-barrel assembly machinery complex. L27-11 targets the OM protein LptD, which is involved in the
transport of LPS to the cell surface. (C) A pool of P. aeruginosa UCBPP-PA14 transposon (Tn) insertion mutants was grown in the absence or presence of antibiotics
and the number of Tn insertion sites were determined by Tn-Seq.
UCBPP-PA14 grown in basal medium 2 (BM2) supplemented
with either high (2 mM) or low (20 µM) Mg2+ (Table 1).
Previous work has shown that under Mg2+-limiting conditions
P. aeruginosa induces expression of the arn gene cluster, which
encodes enzymes that add an L-Ara4N moiety to the phosphate
group of lipid A, thereby conferring resistance to POLs and
other cationic antimicrobial peptides (McPhee et al., 2003, 2006).
Accordingly, we determined that the MICs of PMB and COL
for cells grown with 20 µM Mg2+ are at least 100-fold higher
compared to cells grown in the presence of high Mg2+ (2 mM).
In contrast to these POLs, we observed only a minor twofold
change in susceptibility of P. aeruginosa UCBPP-PA14 to the
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TABLE 1 | Minimum inhibitory concentrations (MICs) of polymyxin B2 (PMB),




Test Agent BM2 (H) BM2 (L)
PMB 0.3 32 2
COL 0.15 64 2
L27-11 1 0.2 0.1
4 0.8 1.6 0.8
3 0.6 1.6 0.6
aMICs were determined in BM2 containing replete (2 mM; High, H) or deplete
(20 µM; Low, L) amounts of Mg2+ in 100 mL Erlenmeyer flasks. Data represent
the mode values of three independent experiments. bSub-MICs of the antibiotics in
BM2 containing deplete (20 µM; Low, L) amounts of Mg2+ were used for growth
of the transposon (Tn) insertion library.
peptidomimetic antibiotics 3 and 4 when grown with 20 µM
Mg2+. The MIC for L27-11 was found to be approximately five
times lower under limiting Mg2+ (20 µM) than under replete
Mg2+ (2 mM) conditions. For the Tn-Seq experiments, we grew
the Tn library of mutants in BM2 containing 20 µM Mg2+
for approximately 12 generations in the presence of sub-MICs
of the different antibiotics that slowed down growth by 30%
compared to the untreated control. The low Mg2+ concentration
of the medium was used to induce resistance to the antimicrobial
peptides (Table 1).
Identification of Fitness Determinants
Involved in Susceptibility to Polymyxins,
L27-11, and Peptides 3 and 4
After extraction of genomic DNA from the harvested Tn pools
of each treatment, the Tn-Seq circle method (Gallagher et al.,
2013) was employed to estimate the number of Tn insertion sites.
Sequencing of the pools from the PMB and COL treatments
resulted in 10.1 and 9.3 million reads, respectively, while
the pools of the treatments with peptidomimetic antibiotics
and the untreated controls resulted in 5.0–10.6 million reads
(Supplementary Table S1). For all the samples, we were able to
map more than 97% of the reads to the P. aeruginosa UCBPP-
PA14 reference genome (Winsor et al., 2016). The number of
unique insertion sites per gene was determined (Solaimanpour
et al., 2015) and the insertion frequency of the Tn was calculated
by dividing the size of the P. aeruginosa UCBPP-PA14 genome
(6.5 Mbp) by the total number of unique insertion sites. We
estimated that the Tn insertion sites are on average spaced by
14 bp in non-essential genes.
We next calculated the unique insertion density (UID) of
each gene (Solaimanpour et al., 2015), which is the number
of unique Tn insertions divided by the length of the gene.
The UIDs were further normalized by the total number of
unique insertions in each sample (normalized UIDs). The genes
providing a fitness benefit for each of the treatments were
determined by selecting a log2-fold change (based on normalized
UIDs) of at least -1.0 between untreated and treated samples,
as detailed in the section “Materials and Methods.” Figure 2
shows the log2-fold change of normalized UIDs of PMB-treated
versus untreated samples plotted against the average normalized
UIDs under both conditions. With the criteria employed, our
analysis identified 58 fitness determinants following treatment
with PMB, 42 for COL, 47 for L27-11, 75 for compound
4, and 43 for compound 3 (Supplementary Tables S2–S7).
These genes were assigned to functional categories according
to clusters of orthologous groups (Huerta-Cepas et al., 2017;
Supplementary Figure S1).
Polymyxins and Peptidomimetics Share
Mechanisms of Resistance
Our Tn-Seq analysis identified 13 genes that had an impact
on susceptibility to all peptide antibiotics tested (Figure 3A
and Table 2). Many of these genes have previously been
shown to affect resistance to PMB or COL, including five
genes of the arn gene cluster (PA14_18330 to PA14_18370),
which directs the addition of L-Ara4N to lipid A. We also
identified several genes of the regulatory systems that are
known to be involved in the regulation of the arn gene cluster
(Jeannot et al., 2017). Among these genes were the two-
component systems pmrAB (PA14_63150 and PA14_63160),
parRS (PA14_41260 and PA14_41270; except for treatment
with peptide 3) and the response regulatory gene phoP of the
PhoPQ system (PA14_49170 and PA14_49180). Another
response regulatory gene that affects expression of the
arn cluster, colR of the ColSR system (PA14_56940 and
PA14_56950), showed a reduced number of Tn insertions
only for the PMB treatment, while higher UIDs were observed
for treatments with peptides 3 and 4 (Log2-fold change -
1.0 versus + 1.29/1.15). In addition to the genes involved
in LPS modification, PA14_58090 encoding a hypothetical
protein and two genes coding for bacteriophage Pf1 proteins
(PA14_48970 and PA14_49000; Kneale, 1983; Davis et al.,
1995) provided a fitness benefit for all tested peptide antibiotics
(Table 2). An involvement of the Pf1 phage in enhanced
resistance to peptide antibiotics is further supported by the
finding that various other Pf1 genes (PA14_48900, PA14_48910,
PA14_48940, PA14_48980, PA14_48990, PA14_49010, and
PA14_49020) were identified upon treatment with the
different antibiotics (Supplementary Table S7). It has been
demonstrated that the filamentous phages produced by
P. aeruginosa cause the biofilm matrix to self-assemble into
a liquid crystal that provides tolerance to aminoglycoside
antibiotics (Secor et al., 2015). In the list of the 13 core genes,
we also identified PA14_42920 coding for the protein HsiJ2,
which is predicted to be the basal plate component (TssK-2) of
the second type VI secretion system (H2-T6SS; Lesic et al., 2009;
Sana et al., 2012).
To assess possible cross-resistances, we compared the fitness
determinants required for growth in the presence of each of
the peptides (Figure 3A). Besides the 13 core genes, the genetic
determinants involved in PMB and COL susceptibility, two
antibiotics with similar mechanisms of action (Kwa et al., 2007),
overlap by 21 genes. Likewise, we observed an overlap of 19
genes between compounds 3 and 4, which target both LPS
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FIGURE 2 | Resistance fitness determinants for polymyxin B2 (PMB). The MA-plot (M for log ratio and A for mean average) shows the average of the normalized
unique insertion density (nUID) between the PMB-treated sample and the untreated sample (log2) on the x-axis and the fold change of the nUID between the two
samples (log2) on the y-axis. The 58 genetic determinants likely involved in bacterial fitness upon PMB exposure are highlighted in red and genes of interest are
named. NC, no change.
FIGURE 3 | Number and clustering of fitness determinants. (A) The identified resistance determinants for the investigated antibiotics substantially overlap. Thirteen
genes impact susceptibility to all tested antibiotics and besides these genes, PMB and colistin (COL) share 21 fitness determinants and peptides (Pep.) 3 and 4 have
19 common genetic determinants. (B) Cluster dendrogram of the Tn-Seq generated in response to PMB, COL, L27-11, peptides 3 and 4 treatments using the Ward
criterion and the Euclidean distance. Peptides PMB/COL and 4/3 were clustered in 100% of the 100,000 iterations (Bootstrap Probability; ***p-value < 0.01).
and BamA (Luther et al., 2019). In contrast, L27-11, which
targets the OM protein LptD, showed fewer overlaps with
the other antibiotics (9 with the POLs and 14 with peptides
3 and 4). These data suggest that the commonalities and
differences between the sets of genes affecting susceptibility
to the different antibiotics may be indicative of their diverse
modes of action. This observation is further supported by
a hierarchical clustering analysis of the Tn-Seq data, which
revealed that PMB and COL and peptides 3 and 4 are
clustered on two branches, while L27-11 forms a separate
branch (Figure 3B).
Resistance Factors Involved in Cell
Envelope Biogenesis
A detailed analysis of our Tn-Seq data revealed that among
the 21 fitness factors specifically affecting resistance to the
two POLs were several genes affecting the structure and
composition of the cell envelope (Supplementary Table S7).
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For example, we identified a gene involved in LPS biosynthesis,
PA14_23370, which encodes an uridine diphosphate (UDP)-N-
acetylglucosamine 2-epimerase (Burrows et al., 1996; Higgins
et al., 2017). In agreement with our data, it has been shown
that mutation of the orthologous gene PA3148 in P. aeruginosa
PAO1 increased OM permeability for the bovine neutrophil
antimicrobial peptide indolicidin (Gooderham et al., 2008).
Interestingly, more Tn insertions were observed in PA14_23370
when the mutant library was treated with L27-11, relative
to the untreated control, indicating an enrichment of this
mutant in the presence of L27-11 (Supplementary Table S7).
Among the core fitness genes is PA14_58090 encoding an
OM protein with a C-terminus homologous to AsmA, which
was suggested to play a role in LPS biosynthesis in E. coli
(Deng and Misra, 1996). While the exact function of AsmA
is unclear, it has been speculated that AsmA plays a role
in OM biogenesis by coordinating the assembly of OM
proteins with the biosynthesis of LPS (Martorana et al.,
2014). We also identified three genes potentially important
for resistance to POLs and chimeras that encode proteins
involved in the recycling of peptidoglycan (Sonnabend et al.,
2020). The lytic transglycosylase SltB1 (PA14_12080) and the
murein endopeptidase MepM1 (PA14_08540), which cleave
peptidoglycan cross-connections, and the AmpG permease
(PA14_57100), which imports peptidoglycan catabolites into
the cytoplasm where they are degraded. To verify a role of
AsmA and peptidoglycan turnover in antibiotic susceptibility,
we tested respective Tn mutants in BM2 supplemented with
20 µM Mg2+. Mutants with defects in asmA, mepM1, sltB1, and
ampG exhibited increased susceptibilities to POLs (2–16 fold). In
contrast, with the exceptions of the twofold increased sensitivities
of themepM1 and asmAmutants to the two chimeras and peptide
3, respectively, the mutations did not affect the sensitivity to the
peptidomimetics (Table 3).
The Role of LPS Modification in Peptide
Antibiotic Susceptibility
To further explore the role of LPS modification in susceptibility,
we determined the expression of the arnB and pmrB genes
by qPCR in Mg2+ replete (2 mM) BM2 in the presence and
absence of sub-MICs of POLs (0.1 µg/ml), L27-11 (0.4 µg/ml),
peptides 3 (0.2 µg/ml) and 4 (0.3 µg/ml). The high Mg2+
concentration was chosen to inhibit LPS modification through
the PhoPQ and PmrAB systems and to determine whether
the antibiotics are capable of inducing LPS modification. Both
genes were found to be up-regulated when the medium was
supplemented with the antimicrobial peptides (Supplementary
Table S8). A six to eightfold induction was observed with
peptide 4, while the other antibiotics caused a two to threefold
induction of arnB and pmrB expression. These data are in full
agreement with previous work showing that various cationic
peptides including PMB induce the pmrAB operon (McPhee
et al., 2003) and suggest that peptide 4 is particularly efficient in
inducing resistance.
We next tested Tn insertion mutants with defects in the
biosynthesis or regulation of LPS modification for increased
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TABLE 3 | Validation of fitness genes in P. aeruginosa UCBPP-PA14.
Locus tag Description Potential resistance PMBa COLa L27-11a 4a 3a
PA14_08540 mepM1 PMB/COL/4 4 2 1 2 2
PA14_12080 sltB1 All (ex. L27-11) 4 2 1 1 1
PA14_57100 ampG PMB/COL/4 4 4 1 1 1
PA14_58090 asmA All 8 16 1 1 2
PA14_18370 arnB All 64 32 8 8 2
PA14_63160 pmrB All 16 8 4 2 2
PA14_49180 phoP All 4 2 1 2 1
PA14_49170 phoQ None 1 1 1 1 1
PA14_41260 parR All (ex. 3) 4 16 1 1 1
PA14_56940 colS None 2 2 2 1 1
PA14_63120 speE L27-11 2 1 4 1 1
aFold-change decrease in MICs (increased susceptibility) relative to the wild-type (1 = MIC between wild-type and mutant is unchanged). Data represent the values of
three independent experiments performed in BM2 containing 20 µM Mg2+. ex., except antibiotics shown.
resistance against the peptide antibiotics in BM2 supplemented
with 20 µM Mg2+. Strains with an inactivated LPS modification
system (arnB) or defects in the regulators controlling expression
of the arn gene cluster (pmrB and parR) exhibited markedly
increased sensitivities to POLs (4–64 fold) and to a lesser
degree (one to eightfold) to L27-11 and peptides 4 and 3
(Table 3). Previous work has shown that the PhoP-PhoQ system
is highly expressed under limiting Mg2+ conditions and is
involved in increased resistance to PMB via activation of the
PmrA-PmrB system (Jeannot et al., 2017). Under Mg2+-limiting
growth conditions, a phoQ mutant of P. aeruginosa PAO1
exhibited constitutive PMB resistance whereas a phoP mutant
was unaffected, as in P. aeruginosa PhoP is not required for
activation of LPS modification in low Mg2+ media (Macfarlane
et al., 2000). Both the Tn-Seq data (Table 2) and the susceptibility
testing of mutants (Table 3) are fully in line with these reports.
Interestingly, the phoP mutant was found to be as susceptible
to L27-11 and peptide 3 as the wild-type strain, despite the fact
that the Tn-Seq analysis suggested a role of PhoP in increased
resistance to these antibiotics. The ParR-ParS system can trigger
upregulation of LPS modification in the presence of sub-MIC
concentrations of POLs (Fernández et al., 2010). Mutants in
parR and parS were shown to be highly sensitive to PMB
and COL but not to other antimicrobial peptides (Fernández
et al., 2010). Accordingly, we observed that a parR Tn insertion
mutant exhibited increased sensitivity for POLs but none of
the peptidomimetics (Table 3). Previous work has shown that
deletion or disruption of the colRS genes, individually or jointly,
abolishes the PMB resistance of a 1phoQ mutant, but has no
significant effect on susceptibility in a wild-type strain (Gutu
et al., 2013). In line with these results, we only identified the
colR gene in our Tn-Seq analysis, and a colS mutant displayed
only a modest twofold increase in sensitivity for POLs and L27-
11 (Table 3).
Spermidine Protects Cells Against
L27-11
We noticed that mutants in three genes (PA14_63110 to
PA14_63130), which are located immediately upstream of pmrAB
were underrepresented in our Tn-Seq analysis of the L27-11
treatment (Supplementary Table S4). Gene PA14_63130was also
identified as important for increased resistance under treatment
with peptide 4. This gene cluster is involved in the biosynthesis
of spermidine, which has been shown to protect bacterial
membranes from oxidative stress and antibiotics, including PMB,
possibly by competing for cation binding sites (Kwon and
Lu, 2007; Johnson et al., 2012). To test the protective effect
of spermidine against the peptide antibiotics, we determined
the MICs of each antimicrobial compound in the wild type
in the presence of spermidine. In agreement with our Tn-Seq
analysis, we observed an eightfold increase in the MIC for L27-
11 and a protective effect was also seen for PMB (Table 4). To
further validate the role of spermidine for resistance to L27-
11 and PMB, we tested a PA14_63120 (speE) Tn mutant, which
is unable to produce spermidine, for antibiotic susceptibility.
The speE mutant exhibited increased susceptibilities to L27-
11 and PMB (two to fourfold), confirming that spermidine
can protect P. aeruginosa against these antibiotics (Table 3).
Our data are in accordance with previous work that has
shown that polyamines induce the expression of phoPQ and
that the increased resistance to polymyxin B was abolished
in a phoP but not in a phoQ mutant, suggesting that the
PhoPQ system crosstalks with an unknown polyamine-specific
signal transduction pathway in P. aeruginosa (Kwon and Lu,
2006, 2007). By contrast, exogenous spermidine increased the
susceptibility of P. aeruginosa to the peptides 3 and 4. This is
TABLE 4 | Minimum inhibitory concentrations of the peptides (PMB, L27-11,
chimeras 3 and 4) in the presence (4 mM) or absence of spermidine in
P. aeruginosa UCBPP-PA14 wild-type.





aMICs of the different antibiotics were determined in BM2 containing 20 µM Mg2+
in microtiter plates. Data represent mode values of three independent experiments.
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FIGURE 4 | Competition between Pseudomonas aeruginosa UCBPP-PA14
wild-type and the mutant tssK-2. The strains were mixed (1:1; B) and grown
until the end of the exponential phase (A) in 20 ml of basal medium 2 (BM2;
20 µM Mg2+) in the presence (2 µg/ml) or absence (untreated) of PMB. Data
represent mean ± SEM of three independent experiments.
reminiscent of a previous report that showed that exogenous
spermine and spermidine increased theMIC of imipenem against
P. aeruginosa (Kwon and Lu, 2006, 2007), likely by blocking the
OM porin OprD, which facilitates the penetration of imipenem
through the OM (Hancock and Brinkman, 2002).
Collectively, these data suggest that the peptidomimetics have
specific and complex interactions with the negatively charged cell
envelope, perhaps through interactions with OM proteins such as
BamA, a known target of these antibiotics (Luther et al., 2019).
PMB Induces Interbacterial Competition
Confirming the results of the Tn-Seq analysis, all tested mutants
showed increased sensitivity to the POLs (Table 3), except the
tssK-2 mutant, which exhibited wild-type levels of sensitivity
to all tested antibiotics (data not shown). Previous studies
revealed that the T6SS of P. aeruginosa is activated upon PMB
treatment (Ho et al., 2013). In addition, expression of the
orthologous gene in P. aeruginosa strain PAO1, PA1667, was
shown to be induced by treatment with a sub-MIC of COL
(Cummins et al., 2009). When a 1:1 mixture of the wild-type
and a tssK-2 Tn mutant was grown in BM2 containing 20 µM
Mg2+ in the presence of a sub-lethal concentration of PMB, we
observed that the tssK-2 mutant was out-competed (Figure 4).
Importantly, this effect was only seen in the presence of PMB.
These data suggest that tssK-2 has no direct function in antibiotic
susceptibility but that the peptide antibiotics trigger bacterial
T6SS-dependent competition. Additional work will be required
to unravel the molecular mechanisms of TssK-2-mediated growth
antagonism and to investigate whether other components of the
second T6SS of P. aeruginosa UCBPP-PA14 are required for the
function of TssK-2.
DISCUSSION
Recent research has identified novel antibiotics that target
essential OM proteins (Ghequire et al., 2018; Storek et al.,
2018a; Hart et al., 2019; Imai et al., 2019; Luther et al., 2019;
Sousa, 2019). While these compounds show great promise for
clinical applications, it is unclear how fast resistance against
this new class of antibiotic may evolve and what the underlying
mechanisms of resistance are. These will be important data for
the clinical development of these antibiotics. In the case of the
peptidomimetics L27-11 and murepavadin (POL7080), earlier
studies linked a greatly increased resistance to both compounds
to rare mutations in the target OM protein LptD (Srinivas
et al., 2010; Werneburg et al., 2012). It is important to note,
however, that our Tn-Seq analysis is unlikely to identify Tn
insertions into essential genes, since these are mostly lethal. In
addition, the mechanism of action of peptides 3 and 4 involves
an interaction with BamA, an essential component of the BAM
complex in the OM (Luther et al., 2019). Nevertheless, it is
important to enquire whether mutations in other genes can affect
the susceptibility of Gram-negative bacteria to these antibiotics.
This is of particular importance in clinical development, where
significant increases in MIC might influence the outcome of
antibiotic treatment.
The aim of this study was, therefore, to identify genetic
determinants in P. aeruginosa UCBPP-PA14 that confer a
fitness benefit when exposed to the peptidomimetic L27-11,
which targets the OM protein LptD (Srinivas et al., 2010;
Werneburg et al., 2012) and the chimeras 3 and 4, which
bind to BamA (Luther et al., 2019). To allow a detailed
comparison, we have also included POLs in this study,
which permeabilize the OM and are thought to depolarize
the CM and cause cell lysis. Many studies have investigated
the mechanisms of resistance to POLs in various Gram-
negative bacteria using classical genetic approaches (Macfarlane
et al., 2000; Fernández et al., 2010, 2013). More recently,
Murray et al. (2015) employed a Tn-Seq approach to identify
resistance mechanisms of P. aeruginosa PAO1 against PMB.
However, this study only identified a single gene that encodes
the hypothetical protein PA14_66150, but none of the well-
characterized resistance determinants.
Here we identified a core set of 13 genes that impact upon
various levels of susceptibility to all peptide antibiotics tested.
Most of these genes encode enzymes for the addition of L-Ara4N
to lipid A or are involved in the complex regulation of their
expression. However, a more detailed analysis revealed important
differences in the role of LPS modification in resistance to the
tested peptide antibiotics. In accordance with previous studies
(Groisman et al., 1997; McPhee et al., 2006), we observed
that under low Mg2+ conditions (20 µM), which induces LPS
modification, the MICs of the wild-type strain for PMB and
COL is increased more than 100-fold relative to those under
replete Mg2+ condition (2 mM; Table 1). In contrast, the
MICs for peptides 3 and 4 only increased by a modest 2-
and 2.5-fold, respectively, and in the case of compound L27-11
sensitivity was found to be even increased. To further evaluate
the role of LPS modification, we determined the MICs of defined
arnB (defective in LPS modification) and pmrB (deficient in
the regulation of the arn biosynthetic cluster) mutants for the
different antibiotics. Both mutants were found to be highly
sensitive to PMB and COL (the MIC of the arnB mutant
against PMB was decreased 64-fold) relative to the wild-type,
whereas the MICs for the peptidomimetics 3, 4 and L27-11
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were only decreased two to eightfold (Table 3). However, even
the relatively small differences in susceptibility were sufficient
to allow selection of mutants in the LPS modification pathway
in our Tn-Seq analysis, indicating the high sensitivity of the
experimental approach. Our data also support the findings of
a recent study, in which strains resistant to POL7080 were
isolated and shown to carry a mutation in the pmrB gene
(Romano et al., 2019).
Our data demonstrate the important and intriguing trend
that L-Ara4N modification of lipid A has only a moderate
effect on susceptibility of P. aeruginosa to the peptidomimetics,
although this lipid A modification is of major importance for
resistance to the POLs in Gram-negative bacteria. This result
might be explained by a different mechanism of action for the
peptidomimetics, involving a specific binding to OM proteins.
Interestingly, a mechanism of action involving an interaction
with BamA has been proposed for lectin-like bacteriocins
(LlpAs), which have been demonstrated to bind both BamA and
LPS via their amino- and carboxy-terminal domains, respectively
(Ghequire et al., 2018). In agreement with our results on
compounds 3 and 4, the authors have shown that the absence of
LPS binding is insufficient to cause full resistance to the LlpAs
(Ghequire et al., 2018). In addition, the bactericidal activity of a
recently described monoclonal antibody MAB1, which binds an
epitope in the external loop L4 on BamA, was found to be linked
to OM fluidity, which in turn is affected by LPS structure (Storek
et al., 2018b). Hence, LPS modification may not only reduce the
attraction of the antibiotics to the OM but could also impact
membrane fluidity and thereby affect the antimicrobial activities
of the compounds.
It is interesting to note that the three peptidomimetics are
active against polymyxin-resistant strains (Sader et al., 2018;
Luther et al., 2019), similar to what has been reported for
some new generation polymyxins (Velkov et al., 2014). It is
thought that these more hydrophobic polymyxin derivatives have
increased potency, because they are insensitive to changes of the
hydrophobic interior of the OM due to modification of lipid
A acylation (Han et al., 2018). However, in the light of recent
findings that some antibiotics bind specifically to essential OM
proteins (Srinivas et al., 2010; Werneburg et al., 2012; Vetterli
et al., 2018), it is possible that the novel polymyxin derivatives,
in addition to their membrane-permeabilizing activities, also
target membrane proteins. Additional work will be required
to investigate this possibility. In addition to general resistance
determinants, our Tn-Seq analysis also identified genes that
provide a fitness benefit for only certain peptidomimetic
antibiotics. This not only increases our understanding of the
mode(s) of action but may also open new options for increasing
the efficacy of these antibiotics.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Bacterial strains, plasmids and primers used in this study are
listed in Supplementary Table S9. Bacterial strains were routinely
grown in lysogeny broth (LB; Miller, 1972) or BM2 (Fernández
et al., 2012) supplemented with glucose as the sole carbon
source. Media were supplemented with appropriate antibiotics
using the following concentrations (in micrograms per milliliter):
(i) for Escherichia coli, gentamicin (Gm) 10, kanamycin (Kan)
25, and trimethoprim (Tp) 50; (ii) for P. aeruginosa, Gm 20,
nalidixic acid (Nal) 10.
Tn-Seq Methodology
The pLG99 plasmid carries the Tn5 derivative Tn23, which is
composed of an outward-facing rhamnose-inducible promoter,
a pMB1 replication origin and a lacZ gene, into which the
gentamicin cassette has been inserted. To do so, the plasmid used
for Tn delivery, pLG99 (Gallagher et al., 2013), was modified
as follows: The gentamicin cassette of plasmid pBBR1MCS-5
(Kovach et al., 1995) was PCR amplified using the primers
Gm_BclI_Fw and Gm_BclI_Rv. The amplicon was cleaned
(QIAquick PCR Purification kit, Cat No./ID:28106), digested
with BclI (New England Biolabs, Cat No. R0160S) and ligated into
pLG99 cut with the same enzyme.
To construct a Tn library in P. aeruginosa UCBPP-PA14
(Rahme et al., 1995), 50 ml LB cultures of the donor strain
E. coli CC118λ-pir/PLG99:Gm, the helper strain E. coli pRK2013
(Phadnis and Berg, 1987) and the recipient P. aeruginosaUCBPP-
PA14 were harvested in the stationary phase, washed and
resuspended in 6 ml 0.9% NaCl. Two hundred fifty microliters
of the donor and the helper strains were mixed and incubated at
room temperature for 10 min before 250µl of the recipient strain
was added. Next, 150 µl samples of the mix were inoculated onto
0.45 µM nitrocellulose membrane filters (Merck Millipore, Ref.
HAQP02500), which were placed on LB agar plates. Following
incubation at 37◦C for 24 h, cells of nine filters were resuspended
in 6 ml of 0.9% NaCl and 0.5 ml of this suspension was spread
on 12 cm–2 square petri dishes containing LB agar supplemented
with Gm 20 µg ml−1 and Nal 10 µg ml−1. After 20 – 24 h
of incubation, the colonies were collected from the plates (417
square petri dishes in total) using 800 µl of LB supplemented
with antibiotics. Afterward, 1.5 ml aliquots were amended with
50% glycerol and stored at -80◦C.
To assess the concentrations of the peptides for challenging
the library, the MICs of the peptides against P. aeruginosa
UCBPP-PA14 were determined. An overnight culture of the
strain was washed with minimal medium BM2 containing 20µM
Mg2SO4 (Fernández et al., 2012), the optical density (OD600)
was adjusted to 0.2 and 1 ml of this suspension was added to
19 ml of BM2 supplemented with 20 µMMg2SO4, 0.002% tween
80 (Sigma-Aldrich), 0.2% of Rhamnose (Sigma-Aldrich) and
different concentrations of the peptide antibiotics (POLs: 8, 12,
16, 32, and 64 µg/ml; L27-11: 0.1, 0.2, and 0.4 µg/ml; chimeras:
0.4, 0.8, and 1.6 µg/ml; 100 mL Erlenmeyer). MICs were defined
as no growth after 10 h, a time point when the non-treated culture
reached the stationary phase. The library was grown overnight
(starting OD600 = 0.01) in BM2 containing 20 µMMg2SO4 to an
OD600 of 0.6, harvested and grown (starting OD600 = 0.01) under
the same conditions exponentially for six generations with and
without the peptides. Cells were harvested (OD600 = 0.6), grown
one more time under the same conditions for six generations
before the cells were harvested and stored at -80◦C.
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Sequencing of the Libraries Challenged
With Peptide Antibiotics
Genomic DNA was extracted using the GenElute Bacterial
Genomic DNA Kits (Cat. No. NA2100-1KT). The libraries were
prepared using the Tn-Seq circle method (Gallagher et al.,
2011) with the following modifications: the NEBNext Ultra
II DNA Library Prep Kit for Illumina (Cat No. E7645S) was
used for end repair and adaptor ligation. DNA fragments
were separated on 1.5% agarose gels and the DNA was
recovered using the QIAquick Gel Extraction Kit (Qiagen, Cat
No./ID:28704). Amplification of the circularized DNA was done
with the PhusionHigh-Fidelity DNAPolymerase (Thermo Fisher
Scientific, Cat. No. F530L). Finally, the library was sequenced
with the modified forward primer “T23_SEQ_G” and the reverse
primer “PE_READ2_SEQ” using the MiSeq reagent kit (V2
300, cycles; Illumina, Ref. MS-102-2002) on the Illumina MiSeq
platform. The adapters and the quality of the demultiplexed
FASTQ reads were trimmed using the command line “cutadapt –
a adapter –q quality –o output.fastq.gz input.fastq.gz” (Martin,
2011). The open source software Tn-Seq Explorer (Solaimanpour
et al., 2015) was used to map the pair reads into the genome
of P. aeruginosa UCBPP-PA14 (Winsor et al., 2016) and to
count the number of Tn insertions using the default “–very-
sensitive” command. The UID was determined with the same
software by dividing the number of unique insertions in each
gene per its length. The UID of each sample was normalized
by the total number of unique insertion sites. The fold change
(log2) was calculated by comparing the normalized UID (nUID)
between the treated cells and the medium control, and this
ratio was used to create a MA-plot, which shows the log2-fold
change of the normalized UIDs on the y-axis and the average
of the normalized UIDs between the PMB-treated sample and
the untreated control on the x-axis. Each dot on the MA-
plot refers to a gene and red dots depict fitness determinants.
From each Tn-Seq data, our custom R-program selected the
genes with a log2-fold change of at least -1.0 and a difference
of at least 0.005 in the nUID between the untreated and the
treated sample, which removed nUID smaller than 0.005 as low
insertion counts may lead to false positive results (Wickham,
2017). The clusters of orthologous groups were assigned by using
the online EggNOG 4.5.1 mapper (Huerta-Cepas et al., 2017)
and Fisher tests were carried out online1 to assess potential
over-representation of an EggNOG category. The R package
“pvclust” was used in order to cluster the peptides according
to the whole Tn-Seq data (nUID) with the Ward criterion and
the Euclidean distance (Suzuki and Shimodaira, 2006) and a
Venn diagram was constructed to compare the mechanisms of
resistance (Dusa, 2018).
Validation of the Tn-Seq Data
To validate the potential implication of some genes in the
resistance to the peptidomimetic antimicrobial compounds, we
looked for the respective mutant strains in the collection of single
Tn insertion P. aeruginosa UCBPP-PA14 mutants (Liberati et al.,
1https://www.graphpad.com/quickcalcs/contingency1.cfm
2006). The localization of Tn insertion was verified by PCR.
After confirming the insertion mutants, the arnB mutant was
grown in the absence and presence of the antibiotic in the same
condition as the library was grown (vide supra). To test all the 11
strains in a high throughput way, the mutants were challenged
with the peptide antibiotics in 200 µl BM2 containing 20 µM
Mg2+ in 96-well-plates (Ref. 655161, Greiner bio-one) and the
growth was recorded at the end of the exponential phase with
the microplate reader “Infinite M200 PRO” (TECAN). To test the
effect of spermidine (4 mM; Sigma-Aldrich) on the activity of the
antimicrobial compounds, the standard twofold dilution MIC in
96-well-plates was performed (Srinivas et al., 2010).
Quantitative Reverse Transcription PCR
(qRT-PCR)
Ribonucleic acid (RNA) was extracted from early stationary
cultures of the UCBPP-PA14 wild-type strain grown in BM2
containing 2 mM Mg2SO4 in the absence (control sample)
or presence of antimicrobial peptides (approximately MIC30
corresponding to 0.1, 0.4, 0.3, and 0.2 µg/ml, for respectively,
PMB, L27-11, 4 and 3). The RNA was further purified
using the RNeasy Qiagen kit (Qiagen, Germany). First strand
cDNA was synthesized using random primers (Invitrogen,
United States) and Murine Leukemia Virus (MLV) reverse
transcriptase (Promega, United States). qPCR was performed
on the generated cDNA using Brilliant III Ultra-Fast SYBR R©
Green QPCRMasterMix (Agilent, United States) and aMx3000P
instrument (Agilent, United States). Relative expression levels
were calculated using the 11 CT method (Pfaffl, 2001) and
the rpoD gene (PA14_07520) was used as the reference gene
for normalization.
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